ATAI Life Sciences N.V. logo

ATAI Life Sciences N.V.

About ATAI Life Sciences N.V.

ATAI Life Sciences N.V. is a clinical-stage biopharmaceutical company founded in 2018 to develop rapid-acting and convenient mental health treatments. In 2025, the company announced an initial bitcoin treasury allocation as part of a treasury diversification strategy.

Last updated: June 29, 2026

Company Details

Explore Bitcoin Services

Compare ATAI Life Sciences N.V. with other Bitcoin financial services on 21Rates:

429 Bitcoin companies tracked · 23 custodians · 33 Bitcoin ETFs · 21 lenders · 22 exchanges · $116B+ tracked ETF AUM · Rates reviewed regularly; see each listing's update date.